Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections |
Dose: Intravenous or Intramuscular Injection – 1-2 g Frequency: once daily Note: up to 4 g/day for severe infections. |
|
Indication: Acute Bacterial Otitis Media |
Dose: Intramuscular Injection – 50 mg/kg Frequency: once |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Children |
Dose: Intravenous or Intramuscular – 50–75 mg/kg/day Frequency: every 24 hours Note: maximum 2 g/day |
|
Indication: Acute Bacterial Otitis Media Age: Children |
Dose: Intramuscular – 50 mg/kg Frequency: single dose Note: not to exceed 1 g |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment: Creatinine Clearance less than 10 mL/min |
Dose: Not specified – 2 g Frequency: once daily Note: Maximum: 2 g daily. |
Administration
- For hospital use only
- Give by IV or IM injection
Side Effect
- Induration after IM injection (5-17%)
- Eosinophilia (6%)
- Thrombocytosis (5%)
- Diarrhea (3%)
- Elevated hepatic transaminases (3%)
- Leukopenia (2%)
- Rash (2%)
- Increased blood urea nitrogen (BUN) (1%)
- Induration at IV site (1%)
- Pain (1%)
- Agranulocytosis
- Anaphylaxis
- Anemia
- Basophilia
- Bronchospasm
- Candidiasis
- Chills
- Diaphoresis
- Dizziness
- Dysgeusia
- Flushing
- Gallstones
- Glycosuria
- Headache
- Hematuria
- Hemolytic anemia
- Increased alkaline phosphatase or bilirubin
- Increased creatinine
- Jaundice
- Leukocytosis
- Lymphocytosis
- Lymphopenia
- Monocytosis
- Nausea
- Neutropenia
- Phlebitis
- Prolonged or decreased prothrombin time (PT)
- Pruritus
- Renal stones
- Serum sickness
- Thrombocytopenia
- Urinary casts
- Vaginitis
- Vomiting
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aminoglycosides
|
May increase nephrotoxicity
|
|
BCG, Typhoid vaccine, Na picosulfate
|
May diminish therapeutic effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hyperbilirubinaemic Neonates
|
Can cause dangerous bilirubin displacement in newborns
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Vial store in a cool, dry place (below 30° C), away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.